Brief: Mainz Biomed N.V. Regains Compliance With Nasdaq Capital Market Listing Requirements
27/01/2025 13:07
Jan 27 (Reuters) - MAINZ BIOMED NV 4TO.F :
* MAINZ BIOMED N.V. REGAINS COMPLIANCE WITH NASDAQ CAPITAL
MARKET
LISTING REQUIREMENTS
* MAINZ BIOMED IS NOW IN FULL COMPLIANCE WITH ALL NASDAQ
CONTINUED
LISTING REQUIREMENTS AND WILL CONTINUE TO BE LISTED AND TRADED
ON NASDAQ CAPITAL MARKET
Source text: ID:nEQb0mQhsa
Further company coverage: 4TO.F
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Quantum Cyber NV
See all newsBrief: Quantum Cyber To Proceed With Pending Litigation Against Adam Gefvert
Brief: Quantum Cyber NV Files Lawsuit Against White Diamond Research, Adam Gefvert And Stocktwits, Inc. In New York Supreme Court
Quantum Cyber jumps on SpaceX stake purchase plan
Brief: Quantum Cyber Signs Loi To Acquire An Estimated 43,000 Square Foot U.S.-Based Manufacturing Facility To Support Mass-Scale Autonomous Drone Production
Brief: Quantum Cyber NV - To Terminate ATM Sales Agreement With Maxim Effective June 7, 2026 - SEC Filing